Not approved for human or veterinary use
Media Inquiries: Public Relations Department, Eisai Co., Ltd
What the Research on BPC-157 Actually Shows Most of the evidence behind BPC-157 is preclinical, meaning the bulk of the research comes from animal studies, specifically on rats, or studies on cells in a lab
It reduces contamination risk but does not prevent chemical degradation of the peptide
This suggests it is cleared from the system quite rapidly, which has major implications for study design and dosing frequency
In this study, although we proved that ex vivo nitric oxide- and endothelium-related vasodilation in normal large vessel was induced only by BPC 157 at high concentration, it could not be ruled out that BPC 157 at low concentration might counteract the imbalanced blood pressure under an in vivo diseased condition through a currently unknown mechanism